Embolic Protection Devices Market - Forecasts from 2017 to 2022
Embolic protection devices market is projected to grow from US$0.812 billion in 2017 to US$1.361 billion in 2022, growing at CAGR of 10.88% over the forecast period. Embolic protection devices (EPD) are used in cardiac procedures to reduce complications arising from debris being released into the bloodstream and causing blockages in smaller vessels. EPD’s are designed to capture and remove debris that may be displaced during procedures. Balloon and catheter occlusion devices form a large part of the market followed by filter systems. Factors driving the market for embolic protection devices are an increase in the number of peripheral and cardiovascular diseases, advancement in minimally invasive procedures, rising aging population and lifestyle changes induced health risks. Geographically North America is the largest market for embolic protection devices.
Research Methodology
This section provides an anatomy of the research process followed for calculating market size and forecasts along with a list of the secondary data sources used and the primary inputs which were taken for data validation. It also provides an outline of the various segmentations which have been covered as part of the report.
Industry Overview
In this section, the entire embolic protection devices market is explained along with the various drivers, restraints and opportunities and the prevalence of the diseases that generate demand. A product pipeline has been mentioned along with innovations in the market. Certain regulations specific to the industry are also listed out, followed by a detailed scenario analysis.
Segmentation
The Embolic Protection Devices Market has been segmented based on type, usage and geography as below:
By Type
Occlusion Systems
Filter Systems
By Usage
Coronary Procedures
Peripheral Procedures
Carotid/Neurological Procedures
Renal Procedures
By Geography
Americas
North America
South America
Europe Middle East and Africa
Europe
Middle East and Africa
Asia Pacific
Market Players
This Section deals with major players in the market, their market shares, products, growth strategies, financials, and recent investments among others. Key industry players in the embolic protection devices market Filters market are Abbott Laboratories, Boston Scientific Corp, Cordis Corporation, and Medtronic among others.
Research Methodology
This section provides an anatomy of the research process followed for calculating market size and forecasts along with a list of the secondary data sources used and the primary inputs which were taken for data validation. It also provides an outline of the various segmentations which have been covered as part of the report.
Industry Overview
In this section, the entire embolic protection devices market is explained along with the various drivers, restraints and opportunities and the prevalence of the diseases that generate demand. A product pipeline has been mentioned along with innovations in the market. Certain regulations specific to the industry are also listed out, followed by a detailed scenario analysis.
Segmentation
The Embolic Protection Devices Market has been segmented based on type, usage and geography as below:
By Type
Occlusion Systems
Filter Systems
By Usage
Coronary Procedures
Peripheral Procedures
Carotid/Neurological Procedures
Renal Procedures
By Geography
Americas
North America
South America
Europe Middle East and Africa
Europe
Middle East and Africa
Asia Pacific
Market Players
This Section deals with major players in the market, their market shares, products, growth strategies, financials, and recent investments among others. Key industry players in the embolic protection devices market Filters market are Abbott Laboratories, Boston Scientific Corp, Cordis Corporation, and Medtronic among others.
1. INTRODUCTION
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. EMBOLIC PROTECTION DEVICES MARKET INDUSTRY OVERVIEW
4.1. Market Overview
4.2. Drivers, Restraints, and Opportunities
4.3. Industry Value Chain Analysis
4.4. Prevalence
4.5. Product Pipeline
4.6. Innovations
4.7. Industry Regulations
4.8. Scenario Analysis
5. EMBOLIC PROTECTION DEVICES MARKET FORECAST BY TYPE (US$ BILLION)
5.1. Occlusion Systems
5.2. Filter Systems
6. EMBOLIC PROTECTION DEVICES MARKET FORECAST BY USAGE (US$ BILLION)
6.1. Coronary Procedures
6.2. Peripheral Procedures
6.3. Carotid/Neurological Procedures
6.4. Renal Procedures
7. EMBOLIC PROTECTION DEVICES MARKET FORECAST BY GEOGRAPHY (US$ BILLION)
7.1. Americas
7.1.1. North America
7.1.2. South America
7.2. Europe Middle East and Africa
7.2.1. Europe
7.2.2. Middle East and Africa
7.3. Asia Pacific
8. COMPETITIVE INTELLIGENCE
8.1. Market Share Analysis
8.2. Investment Analysis
8.3. Recent Deals
8.4. Strategies of Key Players
9. COMPANY PROFILES
9.1. Abbott Laboratories
9.2. Getinge Group
9.3. Biosense Webster (STEREOTAXIS, INC.)
9.4. Boston Scientific Corp
9.5. Cordis Corporation
9.6. Medtronic
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. EMBOLIC PROTECTION DEVICES MARKET INDUSTRY OVERVIEW
4.1. Market Overview
4.2. Drivers, Restraints, and Opportunities
4.3. Industry Value Chain Analysis
4.4. Prevalence
4.5. Product Pipeline
4.6. Innovations
4.7. Industry Regulations
4.8. Scenario Analysis
5. EMBOLIC PROTECTION DEVICES MARKET FORECAST BY TYPE (US$ BILLION)
5.1. Occlusion Systems
5.2. Filter Systems
6. EMBOLIC PROTECTION DEVICES MARKET FORECAST BY USAGE (US$ BILLION)
6.1. Coronary Procedures
6.2. Peripheral Procedures
6.3. Carotid/Neurological Procedures
6.4. Renal Procedures
7. EMBOLIC PROTECTION DEVICES MARKET FORECAST BY GEOGRAPHY (US$ BILLION)
7.1. Americas
7.1.1. North America
7.1.2. South America
7.2. Europe Middle East and Africa
7.2.1. Europe
7.2.2. Middle East and Africa
7.3. Asia Pacific
8. COMPETITIVE INTELLIGENCE
8.1. Market Share Analysis
8.2. Investment Analysis
8.3. Recent Deals
8.4. Strategies of Key Players
9. COMPANY PROFILES
9.1. Abbott Laboratories
9.2. Getinge Group
9.3. Biosense Webster (STEREOTAXIS, INC.)
9.4. Boston Scientific Corp
9.5. Cordis Corporation
9.6. Medtronic
